OTLK Outlook Therapeutics, Inc.

BULLISH Impact: 7/10 Insider Cluster (5 insiders)
Horizon weeks Filed Jun 3, 2026 Processed 1d 21h ago
Insider cluster: 5 insiders, $5.3M total

Price Chart

Loading chart...

Executive Summary

A significant insider buying cluster at Outlook Therapeutics, totaling $5.25M in open-market purchases, is dominated by a $5.0M purchase by Director and 10% Owner Ghiath M. Sukhtian. This buying occurred just days after the company completed a dilutive $4.9M offering and concurrently amended warrants, raising going-concern doubts. The cluster's size (4.6% of market cap) is highly material and suggests insiders see value despite the distressed capital structure.

Key Financial Metrics

Direction
buying
Total Value
$5.3M
Insiders
5

Actionable Insight

The massive insider purchase by the 10% owner at the offering price signals strong conviction despite the going-concern warning. Monitor for further insider buying or a reverse split/restructuring announcement. The stock may re-rate if the market interprets this as a vote of confidence, but the fundamental cash runway risk remains acute.

Key Facts

  • Total insider purchases of $5.25M, representing ~4.6% of OTLK's $114M market cap.
  • Ghiath M. Sukhtian (Director, 10% Owner) purchased 8,539,709 shares at $0.5855 for $5.0M on May 28, 2026.
  • The purchase coincided with a $4.9M registered direct offering at $0.5855 per share, in which Sukhtian was the sole investor.
  • Other directors (Hilzinger, Thurman, Sukhtian Faisal, Haddadin) bought smaller amounts at prices between $0.41 and $0.83.
  • The company has substantial doubt about its ability to continue as a going concern, with cash runway only into September 2026.
  • Cross-filing context includes a 424B5 offering filed 5 days prior, and all calibration amplifiers fire, supporting an elevated impact score.

Financial Impact

Insider purchases of $5.25M represent 4.6% of market cap, a highly material signal. The $5.0M purchase by Sukhtian is effectively the entire offering size, indicating insider alignment with the capital raise.

dilutioncash runwayinsider ownership

Risk Factors

  • Going-concern risk: cash only expected to sustain operations into September 2026.
  • Dilution from the 8.5M share offering and warrant amendments could pressure the stock.
  • Historical performance on OTLK reports shows poor win rate (38%) and negative average alpha at T+20, suggesting the market may not reward this signal.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
78% bullish (9 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-OTLK-1780524225768
20 reports for OTLK
Performance horizon
55% Hit rate 6 of 11 directional calls best @ T+5▲ +38.91%May 27, 2026
Filters
Rows
Reports for OTLK — sortable, filterable
Type Now
Jun 3, 2026
1d ago
Insider Cluster
BULLISH ★ 7/10
$0.8079 awaiting T+1awaiting T+1$0.7959 (−1.49%)
Jun 2, 2026
3d ago
Insider Cluster
MIXED ★ 6/10
awaiting T+1
Jun 1, 2026
3d ago
DEFA14A
BEARISH ★ 6/10
$0.8140 $0.8098▲ +0.52%▼ −0.18%$0.7959 (+2.22%)
Jun 1, 2026
4d ago
8-K
BULLISH ★ 7/10
$0.7300 awaiting T+1awaiting T+1$0.7959 (+9.03%)
May 29, 2026
6d ago
8-K
BEARISH ★ 6/10
$0.8430 $0.8136▲ +3.49%▲ +3.64%$0.7959 (+5.59%)
May 29, 2026
7d ago
424B5
BEARISH ★ 7/10
$0.7300 $0.8430▼ −15.48%▼ −15.20%$0.7959 (−9.03%)
May 28, 2026
7d ago
8-K
BEARISH ★ 7/10
$0.7300 $0.8430▼ −15.48%▼ −15.20%$0.7959 (−9.03%)
May 28, 2026
7d ago
Press Release
BEARISH ★ 7/10
$0.7300 $0.8430▼ −15.48%▼ −15.20%$0.7959 (−9.03%)
May 27, 2026
9d ago
Insider Cluster
BULLISH ★ 5/10
$0.5860 $0.7400▲ +26.28%▲ +25.73%$0.7959 (+35.82%)
May 26, 2026
10d ago
Press Release
BULLISH ★ 8/10
awaiting T+1
Showing 10 of 20

US Market Status

Market Open — Closes in 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access